Bio-Path Holdings
Why Robinhood?
You can watch BPTH and buy or sell other stocks, ETFs, and their options commission-free!About BPTH
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1002, and BP1003.
BPTH Key Statistics
Stock Snapshot
With a market cap of 46.99M, Bio-Path Holdings(BPTH) trades at $3.78. The stock has a price-to-earnings ratio of -3.50.
Bio-Path Holdings(BPTH) stock opened on 2026-02-02 at —. The price climbed to — and dipped to —.
The Bio-Path Holdings(BPTH)'s current trading volume is 0, compared to an average daily volume of 203.55K.
During the past year, Bio-Path Holdings(BPTH) stock moved between $0.32 at its lowest and $2.24 at its peak.
During the past year, Bio-Path Holdings(BPTH) stock moved between $0.32 at its lowest and $2.24 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.